Fortitude Family Office, LLC Beam Therapeutics Inc. Transaction History
Fortitude Family Office, LLC
- $305 Billion
- Q2 2025
A detailed history of Fortitude Family Office, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 31 shares of BEAM stock, worth $522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31Holding current value
$522% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
96.8MCall Options Held
476KPut Options Held
360K-
Farallon Capital Management LLC San Francisco, CA10MShares$169 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$164 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$149 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$129 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$79.7 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.19B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...